SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-161590
Filing Date
2023-06-06
Accepted
2023-06-06 16:01:30
Documents
12
Period of Report
2023-06-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d462478d8k.htm   iXBRL 8-K 23477
  Complete submission text file 0001193125-23-161590.txt   148516

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dawn-20230606.xsd EX-101.SCH 2856
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE dawn-20230606_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dawn-20230606_pre.xml EX-101.PRE 11711
6 EXTRACTED XBRL INSTANCE DOCUMENT d462478d8k_htm.xml XML 3485
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 23996039
SIC: 2834 Pharmaceutical Preparations